China Pharma Holdings rises on treatment agreement
11/09/2019 16:41
** Shares of pharmaceutical co CPHI.A up 4.5% at 26 cents;
highest level since Aug. 5
** Co enters into agreement with World Health Advanced
Technologies Ltd to bring Enercel treatment to China
urn:newsml:reuters.com:*:nPn74w8msa
** Enercel is a homeopathic medication used to treat
infections like drug-sensitive and multi-drug resistant
tuberculosis, hepatitis B and C and diarrhea in children
** CPHI shares marginally up YTD
(Reporting by Dominic Roshan K.L. in Bengaluru)
((Dominic.RoshanKL@thomsonreuters.com;))
Recent news on China Pharma Holdings
See all newsBrief: China Pharma - Not Aware Of Any Material Corporate Developments Explaining Recent Market Activity
Brief: China Pharma Says Co Knows Of No Events That Could Have Caused Unusual Market Activity
Brief: China Pharma Holdings Inc - NYSE American Contacts China Pharma Regarding Unusual Market Activity On May 12 And 13
Brief: China Pharma Holdings Files For Non-Timely 10-K With US SEC
Brief: China Pharma Holdings Inc. Announces 1-For-10 Reverse Stock Split